CS Medica is a Danish company active in medical technology. The company specializes in the development of new medical treatments. The portfolio includes medical cannabis (CBD) products, with the greatest focus on dietary supplements and various treatment care. The products are used, for example, by patients suffering from psoriasis, osteoarthritis, and hair loss. The largest operations are found in the Nordic market, where the products are resold under their own brand.
CEO
Chairperson of the Board
Board
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Lone Henriksen | 37,54 | 37,54 | 2023-03-01 |
| Gitte Henriksen | 32,88 | 32,88 | 2023-03-01 |
| Finn-Ove Henriksen and Nina Henriksen | 3,34 | 3,34 | 2022-06-30 |
| Diaz Capital Invest AB | 3,23 | 3,23 | 2022-08-24 |
| Ylber Rexhepi | 2,32 | 2,32 | 2022-06-30 |
| Tonoy Sayeed | 1,46 | 1,46 | 2022-06-30 |
| Michael Kaa Andersen | 1,18 | 1,18 | 2022-06-30 |
| Tobias Ryde | 1,10 | 1,10 | 2022-06-30 |
| Kent Eklund | 1,03 | 1,03 | 2022-06-30 |
| Taulant Bara | 1,03 | 1,03 | 2022-06-30 |
2023-05-17 Delårsrapport 2023-Q2
2023-07-18 Delårsrapport 2023-Q3
2023-11-17 Bokslutskommuniké 2023